Considering the role of BDNF in the inhibition of depression, PGC1a/FNDC5/BDNF has been determined to be a critical pathway for neuroprotection; as such, it is expected to be an effective target for therapeutic interventions in depressive disorders [14]. This evidence concerns the gene PPARGC1A and depressive symptom measurement.